# Tacrolimus

## Protopic ointment 0.1%，10gm

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | EPROT1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Indications        | Atopic dermatitis (Moderate to Severe)， Second-line Short-term & intermittent long-term therapy in the treatment of patients with moderate to severe atopic dermatitis for 16 years old and above.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | Atopic dermatitis (Moderate to Severe)， Second-line Adolescents (>16 y/o) active phase， Apply thin layer ointment to affected areas twice daily until signs and symptoms resolve; use minimum amount and rub in gently and completely chronic phase: apply ointment as two times a week to three times a week ， re-exame symptoms after 12 months.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Allergic to Tacrolimus， any macrolides， or any other component of Protopic.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | Infections and parasites: Local skin infections， whether or not they have a clear cause， include but are not limited to herpetic eczema， folliculitis， herpes simplex， herpes virus infection， Kaposi's varicella-like rash， Eye herpes infection. Metabolic and nutritional diseases: Alcohol intolerance (face flushing or skin irritation after ingesting alcoholic beverages) Nervous system disease: Sensation abnormalities and dullness (hyperesthesia， burning sensation) Skin and subcutaneous tissue diseases: Itching， acne， vinasse， sunburn Systemic diseases and symptoms of the administration site: Administration site burning， administration site itching， administration site warmth， administration site erythema， administration site pain， administration site irritation， administration site paresthesia， administration site rash， administration site edema |
| Pregnancy          | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

